致力于药物研发关键试剂的生产

15801534258
info@nebulabio.cn
产品名称 NebuSelect™ Recombinant Human FCRL2/IRTA4, His-tag
目录号 NBL-241789
别名 FCRL2/IRTA4; FcR-like protein 2; FcRL2; FCRH2; IFGP4; IRTA4; FCRL2; CD307b; FCRH2SPAP1B; IRTA4SPAP1C; SPAP1; SPAP1A
外观 see COA
分子量 Leu20-Val401
CAS N/A
溶解度 Water Soluble
存储条件 Short term 4℃; Long term -20℃.
保存时间 2 years
备注1 Q96LA5-1
备注2
目录号 规格 价格 库存状态  
NBL-241789-100ug 100ug Inquire Inquire
NBL-241789-1mg 1mg Inquire Inquire
NBL-241789-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Human FCRL2/IRTA4, His-tag


Catalog#:

NBL-241789


Description:

NebuSelect™ Recombinant Human FCRL2/IRTA4, His-tag(Cat#NBL-241789) is expressed in HEK293 with His tag at the C-Terminus.It contains Leu20-Val401.


Species:

Human


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 42.7 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.


Target Name:

FCRL2/IRTA4; FcR-like protein 2; FcRL2; FCRH2; IFGP4; IRTA4; FCRL2; CD307b; FCRH2SPAP1B; IRTA4SPAP1C; SPAP1; SPAP1A


Target Information:

Fc receptor-like 2 (FCRL2) is highly expressed on B-cell chronic lymphocytic leukemia (B-CLL) cells and could possibly influence disease pathogenesis. FCRL2 mRNA expression was found to be expressed at considerably higher levels in peripheral blood mononuclear cells (PBMC) of B-CLL patients compared to controls (range 1.35- to 210-fold upregulation; P < 0.0001) and cells of other hematological diseases.


Amino Acid Sequence: 

Leu20-Val401


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

相关产品